BridgeBio Pharma Inc $ 67.23 1.29 (1.96%)
Volume:
321,055
Avg Vol (1m):
1,037,071
Market Cap $:
10.03 Bil
Enterprise Value $:
9.85 Bil
PE Ratio:
0.00
PB Ratio:
48.64
Financial Strength | 4/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 1.47 | ||
Equity-to-Asset | 0.21 | ||
Debt-to-Equity | 2.95 | ||
Debt-to-EBITDA | -1.14 | ||
Altman Z-Score | 8.19 | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | -1939.45 | ||
Net Margin % | -1832.68 | ||
ROE % | -119.81 | ||
ROA % | -50.85 | ||
ROC (Joel Greenblatt) % | -2502.74 |
BBIO
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 48.64 | ||
PS Ratio | 362.31 | ||
EV-to-EBIT | -23.14 | ||
EV-to-EBITDA | -23.14 | ||
EV-to-Revenue | 448.91 | ||
Current Ratio | 9.85 | ||
Quick Ratio | 9.85 | ||
Days Payable | 1436.49 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 48.48 | ||
Earnings Yield (Greenblatt) % | -4.32 |